Results

Spectrum Pharmaceuticals Inc.

09/18/2021 | Press release | Distributed by Public on 09/18/2021 07:00

Spectrum Pharmaceuticals Presents Late Breaker Oral Presentation of Poziotinib Data in First-Line NSCLC Patients with HER2 Exon 20 Insertion Mutations at ESMO Congress 2021